BGB-900-105

Recruiting

Study of BGB-A1217 in Combination With Tislelizumab in Advanced Solid Tumors

Beigene Study ID info

BGB-900-105

ClinicalTrials.gov ID info

Study Overview

Sex: All

Age: 18 Years and older (Adult, Older Adult)

Accepts Healthy Volunteers? yes

No Study Documents

Locations

Study Overview

Sex: All

Age: 18 Years and older (Adult, Older Adult)

Accepts Healthy Volunteers? yes

No Study Documents